Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Enzamaría Fidilio Meli

Enzamaría Fidilio Meli

Institutions of which they are part

Predoctoral researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca
Enzamaría Fidilio Meli

Enzamaría Fidilio Meli

Enzamaría Fidilio Meli

Institutions of which they are part

Predoctoral researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

¿CONOCER LA PREDISPOSICIÓN GENETICA DEL PACIENTE CON OBESIDAD AYUDA A MEJORAR LA EFICACIA DE LA CIRUGÍA BARIÁTRICA?

IP: -
Collaborators: Marta Comas Martínez, Enzamaría Fidilio Meli
Funding agency: Instituto de Salud Carlos III
Funding: 117370
Reference: PI21/00462
Duration: 01/01/2022 - 30/06/2026

ROL DE LA APELINA EN LA ENFERMEDAD RENAL DIABÉTICA: DEL RATÓN AL HUMANO

IP: Maria Jose Soler Romeo
Collaborators: Marina Lopez Martinez, Jordi Vilardell Vilà, Irene Martinez Diaz, Sheila Bermejo Garcia, Vicent Muñoz Vaño, Carmen Llorens Cebriá, M Antonieta Azancot Rivero, Enzamaría Fidilio Meli, Juan Carlos León Román, Sara Nuñez Delgado
Funding agency: Instituto de Salud Carlos III
Funding: 190000
Reference: PI24/01510
Duration: 01/01/2025 - 31/12/2027

Utilidad del TAC abdominal e inteligencia artificial para la evaluación de la composición corporal y condición metabólica en sujetos con obesidad: estudio FLASH

IP: Andreea Ciudin Mihai
Collaborators: Manuel Escobar Amores, Nuria Roson Gradaille, Fiorella Ximena Palmas Candia, Aitor Rodriguez Martinez, Marta Comas Martínez, Enzamaría Fidilio Meli
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 431460
Reference: CPP2023-010524
Duration: 01/11/2024 - 30/10/2027

Ministerio de Ciencia

Mechanisms of metabolic adaptation after weight loss in obesity. Clinical phenotyping and therapeutic approach.

IP: Andreea Ciudin Mihai
Collaborators: Cristina Gamez Cenzano, Eduard Rodenas Alesina, Ana Marti Delgado, Fiorella Ximena Palmas Candia, Bruno García del Blanco, Ana Belén Méndez Fernández, Ana Maria Ciscar Bellés, Aleix Olivella San emeterio, Marta Comas Martínez, Alvaro Calabuig Goena, Enzamaría Fidilio Meli, Marco Tomasino
Funding agency: Instituto de Salud Carlos III
Funding: 165000
Reference: PI23/01209
Duration: 01/01/2024 - 31/12/2026

Related news

Equip del grup de Diabetis i Metabolisme del VHIR

Fundaluce supports research into a new therapeutic strategy for retinitis pigmentosa

Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss.

Equip projecte ARTEMIs

We study fatty liver and cardiovascular complications with digital twins

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

Carla Maté

The Vall d'Hebron spin-off D-Sight is awarded in EIT Health Innostars 2023 competition

This investment from EIT Health in the project will enable D-Sight to progress in the clinical development of its groundbreaking treatment for the early stages of diabetic retinopathy.

See more

Related professionals

Roberto Orsenigo

Roberto Orsenigo

Predoctoral researcher
Biomedical Research in Melanoma
Read more
Gemma Galán Martinez

Gemma Galán Martinez

P Management and Admin. Project manager
External Strategy Directorate
Read more
Ana Luiza Barbusa De Souza

Ana Luiza Barbusa De Souza

Predoctoral researcher
Infectious Diseases
Read more
Imane EL Haddioui Assarraj

Imane EL Haddioui Assarraj

Maintenance staff and general services
Infectious Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.